Design and synthesis of functionalized glycomers as non-peptidic ligands for SH2 binding and as inhibitors of A-431 human epidermoid and HT-29 colon carcinoma cell lines

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 5, 2000, Pages 439-442

  Hanessian, Stephen ^a   Saavedra, Oscar M ^a   Xie, Fang ^a   Amboldi, Nadia ^b   Battistini, Carlo ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOPYRANOSIDE; GROWTH INHIBITOR; LIGAND;

ARTICLE; CELL CULTURE; COLON CARCINOMA; DRUG DESIGN; DRUG SYNTHESIS; EPIDERMOID TUMOR; HUMAN; HUMAN CELL; LIGAND BINDING;

EID: 0034611089     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00022-6     Document Type: Article

References (30)

1. Smittberger, T.; Waldmann, H. Synlett 1998, 574.
2. Burke T.R. Jr., Yao Z.J., Smyth M.S., Ye B. Curr. Pharm. Des. 3:1997;291.
3. Battistini, C.; Penco, S.; Comoglio, P. M. In Biochemistry of Cell Membranes; Papa, S.; Tager, J. M., Eds.; Birkhäuser Verlag: Switzerland, 1995; p 245.
4. Walton K.M., Dixon J.E. Annu. Rev. Biochem. 62:1993;101.
5. Sawyer T.K. Biopolymers. 47:1998;243.
6. Mayer B.J., Gupta R. Curr. Top. Microbiol. Immunol. 221:1998;1.
7. Kuriyan J., Cowburn D. Annu. Rev. Biophys. Biomol. Struct. 26:1997;259.
8. Botfield M.C., Green J. Annu. Rep. Med. Chem. 30:1995;227.
9. Pike L.J., Gallis B., Casnellie J.E., Bornstein D., Krebs E. G. Proc. Natl. Acad. Sci. USA. 79:1982;1443.
10. Buchdunger E., Trinks U., Meft H., Regenass Urs., Mueller M., Meyer J., McGlynn E., Pinna L.A., Traxler P., Lydon N.B. Proc. Natl. Acad. Sci. USA. 91:1994;2334.
11. Rojas M., Yao S.Y., Lin Y.Z. J. Biol. Chem. 271:1996;27456.
12. Williams E.J., Dunican D.J., Green P.J., Howell F.V., Derossi D., Walsh F.S., Doherty P. J. Biol. Chem. 272:1997;22349.
13. di Renzo M.F., Olivero M., Giacomini A., Porte H., Chastre E., Mirossay L., Nordlinger B., Bretti S., Bottardi S., Giordano S., Plebani M., Gespach G., Comoglio D.M. Clin. Cancer Res. 1:1995;147.
14. Ponzetto C., Bardelli A., Zhen Z., Maina F., dalla Zonca P., Giordano S., Graziani A., Panayotou G., Comoglio D.M. Cell. 77:1994;261.
15. Beattie J. Cell Signal. 2:1996;75.
16. Smithgall T.E. J. Pharmacol. Toxicol. Methods. 34:1995;125.
17. Gishiwzky M.L. Annu. Rep. Med. Chem. 30:1995;247.
18. Brugge J.S. Science. 260:1993;918.
19. Rahuel J., Gay B., Erdmann D., Strauss A., Garcia-Echeverria G., Furet P., Caravatti G., Fretz H., Schoepfer J., Grütter M.G. Nat. Struct. Biol. 3:1996;586.
20. Waksman G., Shoelson S.E., Pant N., Cowburn D., Kuiryan J. Cell. 72:1993;779.
21. Schiering, N.; Casale, E.; Giordano, P.; De Rosa S.; Caccia, P.; Sgarella, L.; Bolis, G.; Battistini, C. The Crystal Structure of the Complex between the Grb2-SH2 Domain and the Tetrapeptide pYVNV. Abstracts No. 231, Keystone Symposium, Keystone, CO, 31 March 1997.
22. Vogel K., Sterling J., Herzig Y., Nadelman A. Tetrahedron. 58:1996;3049.
23. Ogawa T., Matsui M. Carbohydr. Res. 51:1976;C13.
24. Ogawa T., Katano K., Sasajima K., Matsui M. Tetrahedron. 37:1981;2779.
25. David S., Hanessian S. Tetrahedron. 41:1985;643.
26. For a review, see Igarashi, K. Advan. Carbohydr. Chem. Biochem. 1977, 34, 243.
27. Skehan P., Storeng R., Suidiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. J. Natl. Cancer Inst. 82:1990;1107.
28. Rubinstein L.V., Shoemaker R.H., Paull K.D., Simon R.M., Tosini S., Skehan P., Surdiero D.A., Monks A., Boyo M.R. J. Natl. Cancer Inst. 82:1990;1113.
29. See for example, Plummer. M.; Holland, D.; Shahripour, A.; Lunney. E. A.; Fergus, J. H.; Marks, J. S.; McConnell, P.; Mueller, W. T.; Sawyer. T. K. J. Med. Chem. 1997, 40, 3719.
30. See for example, Lee, T. R.; Lawrence, D. S. J. Med. Chem. 1999, 42, 784.